Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4917838 vs placebo and olanzapine in acute exacerbation of schizophrenia
2010-021984-33Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bitopertin in schizophrenia (3 arms), sponsored by Roche. Primary endpoint: Change in PANSS total score from baseline to Day 28. Started Feb 2011; status: completed.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2010-021984-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021984-33.